1. Home
  2. TH vs LXEO Comparison

TH vs LXEO Comparison

Compare TH & LXEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Target Hospitality Corp.

TH

Target Hospitality Corp.

N/A

Current Price

$7.30

Market Cap

669.5M

ML Signal

N/A

Logo Lexeo Therapeutics Inc.

LXEO

Lexeo Therapeutics Inc.

N/A

Current Price

$7.16

Market Cap

731.3M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
TH
LXEO
Founded
1978
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Hotels/Resorts
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
669.5M
731.3M
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
TH
LXEO
Price
$7.30
$7.16
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
10
Target Price
$11.00
$18.60
AVG Volume (30 Days)
329.2K
1.3M
Earning Date
03-25-2026
03-23-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$314,546,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.00
$1.45
52 Week High
$10.12
$10.99

Technical Indicators

Market Signals
Indicator
TH
LXEO
Relative Strength Index (RSI) 41.39 39.55
Support Level $6.70 $6.73
Resistance Level $7.26 $7.91
Average True Range (ATR) 0.22 0.47
MACD 0.00 0.01
Stochastic Oscillator 49.30 40.00

Price Performance

Historical Comparison
TH
LXEO

About TH Target Hospitality Corp.

Target Hospitality Corp is a vertically integrated specialty rental and hospitality services company in the United States. The company provides vertically integrated specialty rental and comprehensive hospitality services including catering food services, maintenance, housekeeping, grounds-keeping, on-site security, overall workforce lodge management, and laundry service. Its operating segment includes HFS-South and HFS-Midwest; Government; TCPL Keystone and others. It generates a majority of its revenue from the Government segment which consists of specialty rental and vertically integrated hospitality services revenue from customers with Government contracts located in Texas.

About LXEO Lexeo Therapeutics Inc.

Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated. The company focuses on preclinical and clinical stage gene therapies, specifically hereditary and acquired diseases with high unmet needs, which represent its sole business segment.

Share on Social Networks: